- Home
- OC vs BMRN Comparison
OC vs BMRN Comparison
Compare OC & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OC
- BMRN
- Stock Information
- Founded
- OC 1938
- BMRN 1996
- Country
- OC United States
- BMRN United States
- Employees
- OC N/A
- BMRN N/A
- Industry
- OC Industrial Machinery/Components
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- OC Industrials
- BMRN Health Care
- Exchange
- OC Nasdaq
- BMRN Nasdaq
- Market Cap
- OC 11.4B
- BMRN 11.1B
- IPO Year
- OC N/A
- BMRN 1999
- Fundamental
- Price
- OC $133.20
- BMRN $54.65
- Analyst Decision
- OC Buy
- BMRN Buy
- Analyst Count
- OC 13
- BMRN 20
- Target Price
- OC $181.92
- BMRN $92.21
- AVG Volume (30 Days)
- OC 1.0M
- BMRN 2.2M
- Earning Date
- OC 11-05-2025
- BMRN 10-28-2025
- Dividend Yield
- OC 2.07%
- BMRN N/A
- EPS Growth
- OC N/A
- BMRN 154.69
- EPS
- OC 3.85
- BMRN 3.40
- Revenue
- OC $11,738,000,000.00
- BMRN $3,063,608,000.00
- Revenue This Year
- OC N/A
- BMRN $13.35
- Revenue Next Year
- OC $1.08
- BMRN $9.18
- P/E Ratio
- OC $34.68
- BMRN $16.09
- Revenue Growth
- OC 26.26
- BMRN 18.36
- 52 Week Low
- OC $123.41
- BMRN $52.48
- 52 Week High
- OC $214.53
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- OC 31.43
- BMRN 47.87
- Support Level
- OC $138.83
- BMRN $53.19
- Resistance Level
- OC $143.47
- BMRN $54.50
- Average True Range (ATR)
- OC 3.42
- BMRN 1.20
- MACD
- OC -1.17
- BMRN 0.29
- Stochastic Oscillator
- OC 4.84
- BMRN 62.43
About OC Owens Corning Inc New
Owens-Corning Inc is a manufacturer of glass fiber utilized in composites and building materials. It has an integrated business model with four reportable segments: Composites, Insulation, Doors, and Roofing. It generates maximum revenue from the Roofing segment. Its Roofing segment laminate and strip asphalt roofing shingles, roofing components, synthetic packaging materials, and oxidized asphalt. It meets the growing demand for longer-lasting, aesthetically attractive laminate products with modest capital investment. Geographically the company generates the majority of its revenue from the United States.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.